MorphImmune has filed a notice of an exempt offering of securities to raise $15,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, MorphImmune is raising $15,000,000.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Clay Siegall played a key…
